RAP 0.00% 20.5¢ resapp health limited

He understands the tech works, I just don't get why it's so hard...

  1. 42 Posts.
    He understands the tech works, I just don't get why it's so hard for the market to understand. RAP are constantly reiterating that the US study "was not an accurate nor reliable evaluation of ResApp's algorithms" and "All parties have reaffirmed their support for a follow-up revised US study this US winter".

    There were numerous issues identified with the US study. Here's the kicker - they created solutions for every single one of them...
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.